secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001104659-25-011517
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio closes $8M public offering, regains Nasdaq minimum bid compliance
-----------------------------------------------------------------------------

- Priced $8M offering of 2.66M shares (or equivalents) and Series C-1/C-2 warrants at $3.01 per unit; closed Feb 10, 2025.
- Net proceeds ~$6.9M; warrants exercisable upon stockholder approval at $3.01/share.
- Received Nasdaq notice of compliance with Bid Price Rule (minimum bid $1.00) after 1-for-50 reverse stock split on Jan 15.
- Company believes it now meets Nasdaq equity rule ($2.5M minimum) following offering; awaiting formal determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/0001104659-25-011517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/tm255743d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-011517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer